Nimble Therapeutics will collaborate with Roche Diagnostics to accelerate the discovery of novel peptide-based molecules for the development of SARS-CoV-2 in vitro diagnostic assays, the company announced today. SARS-CoV-2 is…
Nimble Therapeutics and Swedish company Svar Life Science are collaborating to discover, develop and commercialize diagnostic tests based on Nimble’s novel biomarker discovery engine, the company announced today. “We are…
FluGen, along with Bharat Biotech and virologists at the University of Wisconsin, has begun the development and testing of a unique vaccine against COVID-19 called CoroFlu, the company announced recently….
Exact Sciences is one of four organizations to participate in Gov. Tony Evers’ new public-private partnership to increase Wisconsin’s laboratory testing capacity for COVID-19, the governor announced recently. According to…
BioForward will provide personal protection equipment to Madison-area organizations that serve people with developmental disabilities and seniors, the organization announced recently. “The vulnerable people these organizations assist are at risk…
BrightStar Wisconsin Foundation announced recently that it has invested in Stem Pharm, Inc. Financial terms were not disclosed. As previously reported, the biotech company focuses on creating adult stem cell-derived neural…
Exact Sciences has acquired Paradigm Diagnostics and Viomics to extend its lab testing and research and development capabilities, the company announced recently. According to a release, Paradigm offers a comprehensive…
Stemina Biomarker Discovery announced today that its decTOX quickPredict (devTOXqP) screening platform was able to predict with high accuracy developmental toxicity in humans. The study, which published in the Toxicological Sciences, resulted from…
Promega announced recently that its custom manufacturing is being recognized for supporting the rapid development of a Utah-based company’s new coronavirus test that received CE mark approval earlier this week. According…
Stemina Biomarker Discovery’s recent study on cardiovascular toxicity was published in the Toxicological Sciences journal this month, the company announced recently. According to a release, the study suggests that the results…
